Synthego valuation, funding and investors

Synthego works in CRISPR solutions development, based in Redwood City, United States. Founded in 2012, it has about 163 employees.

Pharmaceutical Products Series E

VALUATION · TODAY

$1.47B −1% after Series E

Range $115M – $3.25B · Grade D

TODAY

+12 MO

$1.00B

$2.00B

$3.00B

$4.00B

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

Series B $41.9M

Series C $110M

Series D $100M

Series E $200M

ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then

HEADCOUNT · TODAY163 employees

+0%6m growth

+0%1y growth

−40%2y growth

250

500

Data from Jan 2021

TODAY

Predicted in 1 yr $1.45B −1% vs today

Predicted next raise $252M if a round comes

Winding-down probability 16%

Last round: Series E · $200M · Feb 2022
Valuation at last round: $1.76B · implied
Headcount: 163
Grade: D
Founded: 2012

How VCMC values companies →

Synthego valuation today

VCMC values Synthego at $1.5B today, with a range of $115M to $3.3B and a grade of D. The valuation starts from its last funding round, a Series E round in Feb 2022.

Valuation by date (183 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

Synthego: valuation by date, as the model would have shown it on each date
Date	Valuation	Range	Predicted in 1 yr	Phase	Headcount	Trend	Grade	Winding-down probability
1 Jan 2012	$4.67M	$1.70M – $12.8M	$4.78M (+2%)	before first round	–	unknown	D	0%
1 Feb 2012	$4.67M	$1.70M – $12.8M	$4.80M (+3%)	before first round	–	unknown	D	0%
1 Mar 2012	$4.67M	$1.70M – $12.8M	$4.82M (+3%)	before first round	–	unknown	D	0%
1 Apr 2012	$4.67M	$1.70M – $12.8M	$4.84M (+4%)	before first round	–	unknown	D	0%
1 May 2012	$4.67M	$1.70M – $12.8M	$4.86M (+4%)	before first round	–	unknown	D	0%
1 Jun 2012	$4.67M	$1.70M – $12.8M	$4.88M (+4%)	before first round	–	unknown	D	0%
1 Jul 2012	$4.67M	$1.70M – $12.8M	$4.90M (+5%)	before first round	–	unknown	D	0%
1 Aug 2012	$4.69M	$1.71M – $12.9M	$4.92M (+5%)	before first round	–	unknown	D	0%
1 Sep 2012	$4.71M	$1.71M – $12.9M	$4.94M (+5%)	before first round	–	unknown	D	0%
1 Oct 2012	$4.73M	$1.72M – $13.0M	$4.96M (+5%)	before first round	–	unknown	D	0%
1 Nov 2012	$4.75M	$1.73M – $13.0M	$4.98M (+5%)	before first round	–	unknown	D	0%
1 Dec 2012	$4.77M	$1.74M – $13.1M	$4.99M (+5%)	before first round	–	unknown	D	0%
1 Jan 2013	$4.78M	$1.74M – $13.1M	$5.01M (+5%)	before first round	–	unknown	D	0%
1 Feb 2013	$4.80M	$1.75M – $13.2M	$5.03M (+5%)	before first round	–	unknown	D	0%
1 Mar 2013	$4.82M	$1.75M – $13.2M	$5.05M (+5%)	before first round	–	unknown	D	0%
1 Apr 2013	$4.84M	$1.76M – $13.3M	$5.07M (+5%)	before first round	–	unknown	D	0%
1 May 2013	$4.86M	$1.77M – $13.3M	$5.09M (+5%)	before first round	–	unknown	D	0%
1 Jun 2013	$4.88M	$1.78M – $13.4M	$5.11M (+5%)	before first round	–	unknown	D	0%
1 Jul 2013	$4.90M	$1.78M – $13.5M	$5.13M (+5%)	before first round	–	unknown	D	0%
1 Aug 2013	$4.92M	$1.79M – $13.5M	$5.15M (+5%)	before first round	–	unknown	D	0%
1 Sep 2013	$4.94M	$1.80M – $13.6M	$5.17M (+5%)	before first round	–	unknown	D	0%
1 Oct 2013	$4.95M	$1.80M – $13.6M	$5.19M (+5%)	before first round	–	unknown	D	0%
1 Nov 2013	$4.97M	$1.81M – $13.7M	$5.21M (+5%)	before first round	–	unknown	D	0%
1 Dec 2013	$4.99M	$1.82M – $13.7M	$5.23M (+5%)	before first round	–	unknown	D	0%
1 Jan 2014	$5.01M	$1.83M – $13.8M	$5.25M (+5%)	before first round	–	unknown	D	0%
1 Feb 2014	$5.03M	$1.83M – $13.8M	$5.28M (+5%)	before first round	–	unknown	D	0%
1 Mar 2014	$5.05M	$1.84M – $13.9M	$5.29M (+5%)	before first round	–	unknown	D	0%
1 Apr 2014	$5.07M	$1.85M – $13.9M	$5.32M (+5%)	before first round	–	unknown	D	0%
1 May 2014	$5.09M	$1.85M – $14.0M	$5.34M (+5%)	before first round	–	unknown	D	0%
1 Jun 2014	$5.11M	$1.86M – $14.0M	$5.36M (+5%)	before first round	–	unknown	D	0%
1 Jul 2014	$5.13M	$1.87M – $14.1M	$5.38M (+5%)	before first round	–	unknown	D	0%
1 Aug 2014	$5.15M	$1.88M – $14.2M	$5.40M (+5%)	before first round	–	unknown	D	0%
1 Sep 2014	$5.17M	$1.88M – $14.2M	$5.42M (+5%)	before first round	–	unknown	D	0%
1 Oct 2014	$5.19M	$1.89M – $14.3M	$5.44M (+5%)	before first round	–	unknown	D	0%
1 Nov 2014	$5.21M	$1.90M – $14.3M	$5.46M (+5%)	before first round	–	unknown	D	0%
1 Dec 2014	$5.23M	$1.91M – $14.4M	$5.48M (+5%)	before first round	–	unknown	D	0%
1 Jan 2015	$5.25M	$1.91M – $14.4M	$5.51M (+5%)	before first round	–	unknown	D	0%
1 Feb 2015	$5.28M	$1.92M – $14.5M	$5.53M (+5%)	before first round	–	unknown	D	0%
1 Mar 2015	$5.29M	$1.93M – $14.5M	$5.55M (+5%)	before first round	–	unknown	D	0%
1 Apr 2015	$5.32M	$1.93M – $14.6M	$5.57M (+5%)	before first round	–	unknown	D	0%
1 May 2015	$5.34M	$1.94M – $14.7M	$5.59M (+5%)	before first round	–	unknown	D	0%
1 Jun 2015	$5.36M	$1.95M – $14.7M	$5.61M (+5%)	before first round	–	unknown	D	0%
1 Jul 2015	$5.38M	$1.96M – $14.8M	$5.64M (+5%)	before first round	–	unknown	D	0%
1 Aug 2015	$5.40M	$1.97M – $14.8M	$5.78M (+7%)	before first round	–	unknown	D	0%
1 Sep 2015	$5.42M	$1.97M – $14.9M	$5.94M (+10%)	before first round	–	unknown	D	0%
1 Oct 2015	$5.44M	$1.98M – $14.9M	$6.09M (+12%)	before first round	–	unknown	D	0%
1 Nov 2015	$5.46M	$1.99M – $15.0M	$6.26M (+15%)	before first round	–	unknown	D	0%
1 Dec 2015	$5.48M	$2.00M – $15.1M	$6.42M (+17%)	before first round	–	unknown	D	0%
1 Jan 2016	$5.51M	$2.00M – $15.1M	$6.60M (+20%)	before first round	–	unknown	D	0%
1 Feb 2016	$5.53M	$2.01M – $15.2M	$6.78M (+23%)	before first round	–	unknown	D	0%
1 Mar 2016	$5.55M	$2.02M – $15.2M	$6.95M (+25%)	before first round	–	unknown	D	0%
1 Apr 2016	$5.57M	$2.03M – $15.3M	$7.14M (+28%)	before first round	–	unknown	D	0%
1 May 2016	$5.59M	$2.04M – $15.4M	$7.33M (+31%)	before first round	–	unknown	D	0%
1 Jun 2016	$5.61M	$2.04M – $15.4M	$7.53M (+34%)	before first round	–	unknown	D	0%
1 Jul 2016	$5.64M	$2.05M – $15.5M	$7.72M (+37%)	before first round	–	unknown	D	0%
1 Aug 2016	$5.79M	$2.11M – $15.9M	$7.93M (+37%)	before first round	–	unknown	D	0%
1 Sep 2016	$5.94M	$2.16M – $16.3M	$8.15M (+37%)	before first round	–	unknown	D	0%
1 Oct 2016	$6.10M	$2.22M – $16.8M	$8.36M (+37%)	before first round	–	unknown	D	0%
1 Nov 2016	$6.26M	$2.28M – $17.2M	$8.59M (+37%)	before first round	–	unknown	D	0%
1 Dec 2016	$6.43M	$2.34M – $17.7M	$8.81M (+37%)	before first round	–	unknown	D	0%
1 Jan 2017	$6.60M	$2.40M – $18.1M	$9.05M (+37%)	before first round	–	unknown	D	0%
5 Jan 2017	$299M	$197M – $683M	$449M (+50%)	after a round	–	unknown	C	0%
1 Feb 2017	$309M	$197M – $683M	$449M (+45%)	after a round	–	unknown	C	0%
1 Mar 2017	$318M	$197M – $683M	$449M (+41%)	after a round	–	unknown	C	0%
1 Apr 2017	$329M	$197M – $683M	$449M (+36%)	after a round	–	unknown	C	0%
1 May 2017	$341M	$197M – $683M	$449M (+32%)	after a round	–	unknown	C	0%
1 Jun 2017	$353M	$197M – $683M	$449M (+27%)	after a round	–	unknown	C	0%
1 Jul 2017	$364M	$197M – $683M	$449M (+23%)	after a round	–	unknown	C	0%
1 Aug 2017	$377M	$197M – $683M	$449M (+19%)	after a round	–	unknown	C	0%
1 Sep 2017	$390M	$197M – $683M	$449M (+15%)	after a round	–	unknown	C	0%
1 Oct 2017	$404M	$197M – $683M	$449M (+11%)	after a round	–	unknown	C	0%
1 Nov 2017	$418M	$197M – $683M	$449M (+7%)	after a round	–	unknown	C	0%
1 Dec 2017	$432M	$197M – $683M	$449M (+4%)	after a round	–	unknown	C	0%
1 Jan 2018	$447M	$197M – $683M	$449M (0%)	after a round	–	unknown	C	0%
1 Feb 2018	$449M	$189M – $683M	$449M (0%)	after a round	–	unknown	C	0%
1 Mar 2018	$449M	$182M – $683M	$449M (0%)	after a round	–	unknown	C	0%
1 Apr 2018	$449M	$174M – $683M	$449M (0%)	after a round	–	unknown	C	0%
1 May 2018	$449M	$166M – $683M	$449M (0%)	after a round	–	unknown	C	0%
1 Jun 2018	$449M	$159M – $683M	$449M (0%)	after a round	–	unknown	C	0%
1 Jul 2018	$449M	$153M – $683M	$449M (0%)	after a round	–	unknown	C	0%
1 Aug 2018	$449M	$146M – $683M	$449M (0%)	after a round	–	unknown	C	0%
1 Sep 2018	$449M	$140M – $683M	$449M (0%)	after a round	–	unknown	C	0%
1 Oct 2018	$449M	$134M – $683M	$449M (0%)	after a round	–	unknown	C	0%
24 Oct 2018	$852M	$600M – $1.6B	$1.1B (+30%)	after a round	–	unknown	B	0%
1 Nov 2018	$857M	$600M – $1.6B	$1.1B (+29%)	after a round	–	unknown	B	0%
1 Dec 2018	$876M	$600M – $1.6B	$1.1B (+26%)	after a round	–	unknown	B	0%
1 Jan 2019	$896M	$600M – $1.6B	$1.1B (+24%)	after a round	–	unknown	B	0%
1 Feb 2019	$916M	$600M – $1.6B	$1.1B (+21%)	after a round	–	unknown	B	0%
1 Mar 2019	$934M	$600M – $1.6B	$1.1B (+18%)	after a round	–	unknown	B	0%
1 Apr 2019	$956M	$600M – $1.6B	$1.1B (+16%)	after a round	–	unknown	B	0%
1 May 2019	$976M	$600M – $1.6B	$1.1B (+13%)	after a round	–	unknown	B	0%
1 Jun 2019	$998M	$600M – $1.6B	$1.1B (+11%)	after a round	–	unknown	B	0%
1 Jul 2019	$1.0B	$600M – $1.6B	$1.1B (+9%)	after a round	–	unknown	B	0%
1 Aug 2019	$1.0B	$600M – $1.6B	$1.1B (+6%)	after a round	–	unknown	B	0%
1 Sep 2019	$1.1B	$600M – $1.6B	$1.1B (+4%)	after a round	–	unknown	B	0%
1 Oct 2019	$1.1B	$600M – $1.6B	$1.1B (+2%)	after a round	–	unknown	B	0%
1 Nov 2019	$1.1B	$592M – $1.6B	$1.1B (0%)	after a round	–	unknown	B	0%
1 Dec 2019	$1.1B	$566M – $1.6B	$1.1B (0%)	after a round	–	unknown	B	0%
1 Jan 2020	$1.1B	$541M – $1.6B	$1.1B (0%)	after a round	–	unknown	B	0%
1 Feb 2020	$1.1B	$516M – $1.6B	$1.1B (0%)	after a round	–	unknown	B	0%
1 Mar 2020	$1.1B	$494M – $1.6B	$1.1B (0%)	after a round	–	unknown	B	0%
1 Apr 2020	$1.1B	$472M – $1.6B	$1.1B (0%)	after a round	–	unknown	C	0%
1 May 2020	$1.1B	$451M – $1.6B	$1.1B (0%)	after a round	–	unknown	C	0%
1 Jun 2020	$1.1B	$431M – $1.6B	$1.1B (0%)	after a round	–	unknown	C	0%
1 Jul 2020	$1.1B	$412M – $1.6B	$1.1B (0%)	after a round	–	unknown	C	0%
1 Aug 2020	$1.1B	$393M – $1.6B	$1.1B (0%)	after a round	–	unknown	C	0%
27 Aug 2020	$487M	$423M – $728M	$633M (+30%)	after a round	–	unknown	A	0%
1 Sep 2020	$489M	$423M – $728M	$633M (+29%)	after a round	–	unknown	A	0%
1 Oct 2020	$499M	$423M – $728M	$633M (+27%)	after a round	–	unknown	A	0%
1 Nov 2020	$511M	$423M – $728M	$633M (+24%)	after a round	–	unknown	A	0%
1 Dec 2020	$522M	$423M – $728M	$633M (+21%)	after a round	–	unknown	A	0%
1 Jan 2021	$533M	$423M – $728M	$633M (+19%)	after a round	250	unknown	A	0%
1 Feb 2021	$546M	$423M – $728M	$633M (+16%)	after a round	250	unknown	A	0%
1 Mar 2021	$557M	$423M – $728M	$633M (+14%)	after a round	250	unknown	A	0%
1 Apr 2021	$569M	$423M – $728M	$633M (+11%)	after a round	250	unknown	A	0%
1 May 2021	$582M	$423M – $728M	$633M (+9%)	after a round	250	unknown	A	0%
1 Jun 2021	$595M	$423M – $728M	$633M (+6%)	after a round	250	unknown	A	0%
1 Jul 2021	$608M	$423M – $728M	$633M (+4%)	after a round	250	unknown	A	0%
1 Aug 2021	$621M	$423M – $728M	$633M (+2%)	after a round	250	unknown	A	0%
1 Sep 2021	$633M	$419M – $728M	$633M (0%)	after a round	250	unknown	A	0%
1 Oct 2021	$633M	$401M – $728M	$633M (0%)	after a round	250	unknown	A	0%
1 Nov 2021	$633M	$383M – $728M	$633M (0%)	after a round	250	unknown	B	0%
1 Dec 2021	$633M	$366M – $728M	$633M (0%)	after a round	250	unknown	B	0%
1 Jan 2022	$633M	$349M – $728M	$633M (0%)	after a round	250	unknown	B	0%
1 Feb 2022	$633M	$334M – $728M	$633M (0%)	after a round	250	unknown	B	0%
18 Feb 2022	$1.8B	$1.2B – $3.3B	$2.3B (+30%)	after a round	250	unknown	B	0%
1 Mar 2022	$1.8B	$1.2B – $3.3B	$2.3B (+29%)	after a round	250	unknown	B	0%
1 Apr 2022	$1.8B	$1.2B – $3.3B	$2.3B (+26%)	after a round	250	unknown	B	0%
1 May 2022	$1.9B	$1.2B – $3.3B	$2.3B (+23%)	after a round	250	unknown	B	0%
1 Jun 2022	$1.9B	$1.2B – $3.3B	$2.3B (+21%)	after a round	250	unknown	B	0%
1 Jul 2022	$1.9B	$1.2B – $3.3B	$2.3B (+18%)	after a round	250	unknown	B	0%
1 Aug 2022	$2.0B	$1.2B – $3.3B	$2.3B (+15%)	after a round	250	unknown	B	0%
1 Sep 2022	$2.0B	$1.2B – $3.3B	$2.3B (+13%)	after a round	250	unknown	B	0%
1 Oct 2022	$2.1B	$1.2B – $3.3B	$2.3B (+11%)	after a round	250	unknown	B	0%
1 Nov 2022	$2.1B	$1.2B – $3.3B	$2.3B (+8%)	after a round	250	unknown	B	0%
1 Dec 2022	$2.2B	$1.2B – $3.3B	$2.3B (+6%)	after a round	420	unknown	B	0%
1 Jan 2023	$2.2B	$1.2B – $3.3B	$2.3B (+3%)	after a round	420	unknown	B	0%
1 Feb 2023	$2.3B	$1.2B – $3.3B	$2.3B (+1%)	after a round	420	unknown	B	0%
1 Mar 2023	$2.3B	$1.2B – $3.3B	$2.3B (0%)	after a round	420	unknown	B	0%
1 Apr 2023	$2.3B	$1.2B – $3.3B	$2.3B (0%)	after a round	420	unknown	B	0%
1 May 2023	$2.3B	$1.1B – $3.3B	$2.3B (0%)	after a round	420	unknown	B	0%
1 Jun 2023	$2.3B	$1.1B – $3.3B	$2.3B (0%)	after a round	420	unknown	B	0%
1 Jul 2023	$2.3B	$1.0B – $3.3B	$2.3B (0%)	after a round	420	unknown	B	0%
1 Aug 2023	$2.3B	$972M – $3.3B	$2.3B (0%)	after a round	420	unknown	C	0%
1 Sep 2023	$2.3B	$928M – $3.3B	$2.3B (0%)	after a round	420	unknown	C	0%
1 Oct 2023	$2.3B	$887M – $3.3B	$2.3B (0%)	after a round	420	unknown	C	0%
1 Nov 2023	$1.3B	$815M – $2.5B	$837M (-37%)	after a round	310	shrinking	B	97%
1 Dec 2023	$1.3B	$776M – $2.5B	$807M (-37%)	after a round	310	shrinking	B	97%
1 Jan 2024	$1.2B	$738M – $2.5B	$777M (-37%)	after a round	310	shrinking	C	97%
1 Feb 2024	$1.2B	$701M – $2.5B	$748M (-37%)	after a round	310	shrinking	C	97%
1 Mar 2024	$1.1B	$668M – $2.3B	$677M (-40%)	after a round	280	shrinking	C	97%
1 Apr 2024	$1.1B	$635M – $2.3B	$649M (-40%)	after a round	270	shrinking	C	97%
1 May 2024	$1.0B	$605M – $2.3B	$623M (-40%)	after a round	270	shrinking	C	97%
1 Jun 2024	$1.0B	$575M – $2.3B	$597M (-41%)	after a round	270	shrinking	C	97%
1 Jul 2024	$1.3B	$547M – $3.0B	$846M (-33%)	after a round	270	down	C	89%
1 Aug 2024	$1.3B	$520M – $3.1B	$887M (-31%)	after a round	270	down	C	82%
1 Sep 2024	$1.3B	$494M – $3.1B	$915M (-31%)	after a round	270	down	C	77%
1 Oct 2024	$1.3B	$470M – $3.1B	$891M (-31%)	after a round	270	down	C	77%
1 Nov 2024	$1.3B	$447M – $3.2B	$867M (-32%)	after a round	270	down	C	77%
1 Dec 2024	$1.2B	$426M – $3.2B	$844M (-32%)	after a round	270	down	D	77%
1 Jan 2025	$1.2B	$404M – $3.2B	$821M (-33%)	after a round	270	down	D	77%
1 Feb 2025	$1.2B	$384M – $3.2B	$798M (-33%)	after a round	270	down	D	77%
1 Mar 2025	$1.1B	$367M – $3.3B	$733M (-32%)	after a round	270	down	D	77%
1 Apr 2025	$1.1B	$349M – $3.2B	$712M (-32%)	after a round	270	down	D	77%
1 May 2025	$1.1B	$332M – $3.2B	$754M (-31%)	after a round	270	flat	D	71%
1 Jun 2025	$1.1B	$316M – $3.2B	$795M (-29%)	after a round	270	flat	D	65%
1 Jul 2025	$1.2B	$300M – $3.2B	$837M (-28%)	after a round	270	flat	D	60%
1 Aug 2025	$1.2B	$285M – $3.2B	$876M (-27%)	after a round	270	flat	D	55%
1 Sep 2025	$1.3B	$271M – $3.3B	$987M (-22%)	after a round	270	unknown	D	51%
1 Oct 2025	$1.3B	$258M – $3.3B	$1.0B (-20%)	after a round	163	unknown	D	47%
1 Nov 2025	$1.3B	$245M – $3.3B	$1.1B (-19%)	after a round	163	unknown	D	43%
1 Dec 2025	$1.4B	$234M – $3.3B	$1.1B (-18%)	after a round	163	unknown	D	39%
1 Jan 2026	$1.4B	$222M – $3.3B	$1.2B (-16%)	after a round	163	unknown	D	36%
1 Feb 2026	$1.5B	$211M – $3.3B	$1.3B (-14%)	after a round	163	unknown	D	33%
1 Mar 2026	$1.5B	$202M – $3.3B	$1.3B (-10%)	after a round	163	unknown	D	31%
1 Apr 2026	$1.5B	$192M – $3.3B	$1.4B (-8%)	after a round	163	unknown	D	28%
1 May 2026	$1.5B	$182M – $3.3B	$1.4B (-7%)	after a round	163	unknown	D	26%
1 Jun 2026	$1.6B	$173M – $3.3B	$1.5B (-5%)	after a round	163	unknown	D	24%
1 Jul 2026	$1.6B	$165M – $3.3B	$1.5B (-4%)	after a round	163	unknown	D	22%
1 Aug 2026	$1.6B	$157M – $3.3B	$1.6B (-3%)	after a round	163	unknown	D	20%
1 Sep 2026	$1.7B	$149M – $3.3B	$1.6B (-2%)	after a round	163	unknown	D	19%
1 Oct 2026	$1.7B	$142M – $3.3B	$1.7B (-2%)	after a round	163	unknown	D	17%
24 Oct 2026	$1.5B	$115M – $3.3B	$1.5B (-1%)	after a round	163	unknown	D	16%

Key facts about Synthego

Founded: 2012
Headquarters: Redwood City, United States
Employees: about 163
Total raised: $452M
Funding rounds: 4
Last round: Series E Feb 2022

Synthego was founded in 2012 by Michael Dabrowski and Paul Dabrowski.

Synthego funding history

Synthego has 4 funding rounds on record, from Jan 2017 to Feb 2022, $452M in total. The latest disclosed valuation is $487M post-money (Series D, Aug 2020).

Series E 17 Feb 2022
Led by Perceptive Advisors; with SoftBank Vision Fund, Declaration Partners, Laurion Capital Management, Logos Capital, Gigafund, Chimera Abu Dhabi, Wellington Management, RA Capital, Moore Strategic Ventures.
Sources: declarationpartners.com, synthego.com, verdict.co.uk
$200M
Series D 26 Aug 2020
Led by 8VC, RA Capital, Wellington Management; with Founders Fund, Intel Capital, Menlo Ventures.
Sources: prnewswire.com, finsmes.com
$100M
$487M post-money
Series C 23 Oct 2018
Led by Founders Fund; with 8VC, Menlo Ventures.
Sources: finsmes.com, chiefhealthcareexecutive.com, techcrunch.com and 3 more
$110M
Series B 4 Jan 2017
Led by 8VC; with AME Cloud Ventures, Element Capital, Founders Fund, Menlo Ventures, OS Fund, SciFi VC, WI Harper Group, ZhenFund, Alexandria Equities. Individuals: Jennifer A. Doudna, Jennifer Doudna.
Sources: finance.yahoo.com, bondoro.com, synbiobeta.com
$42M

Synthego investors

21 investors have backed Synthego; 8VC, Founders Fund and RA Capital and 2 more led at least one round.

8VC lead, 3 rounds
Founders Fund lead, 3 rounds
Wellington Management lead, 2 rounds
Menlo Ventures 3 rounds
Alexandria Equities
AME Cloud Ventures
Chimera Abu Dhabi
Intel Capital
Laurion Capital Management
Moore Strategic Ventures
OS Fund
SoftBank Vision Fund
ZhenFund

What Synthego does

Synthego works in pharmaceutical products, with 14 recorded offerings and customers in biotechnology, life sciences and pharmaceuticals.

Synthego Corporation is an American biotechnology company engaged in CRISPR solutions and molecular diagnostics products for life science research and development. The company provides CRISPR gene editing tools, molecular diagnostics products, and custom manufacturing services, with a focus on regulatory compliance and GMP manufacturing. Synthego serves a global market and operates through a network of authorized distributors and partnerships.

Description from Veridion's company data.

Products and services

CRISPR Solutions Development
CRISPR Gene Editing Tool Manufacturing
Engineered Nuclease Production
Base Editor Production
CRISPR Gene Editor Production
Molecular Diagnostics Product Manufacturing
Custom CRISPR Product Manufacturing
GMP-Compliant Product Manufacturing
Regulatory Compliance Consulting
Clinical sgRNA Batch Production
Therapeutic Development Support Services
Life Science Research Services
Biotechnology Innovation Consulting
Global Product Distribution

Markets

Biotechnology
Life Sciences
Pharmaceuticals

Technology

CRISPR Gene Editing Technology
Engineered Nucleases
Base Editors

Business model

Business-to-Business
Service Provider
Manufacturing
Wholesale

Industry codes (NAICS)

325414 Biological Product (except Diagnostic) Manufacturing 70% match
424210 Drugs and Druggists' Sundries Merchant Wholesalers 30% match

Questions about Synthego

What is Synthego worth?

Valuation $1.5B (range $115M to $3.3B), as of 24 Oct 2026. The last disclosed valuation was $487M (Series D, Aug 2020).

Has Synthego raised money?

Synthego has 4 funding rounds on record, from Jan 2017 to Feb 2022, $452M in total. The latest disclosed valuation is $487M post-money (Series D, Aug 2020).

Who has invested in Synthego?

8VC, Founders Fund, RA Capital, Wellington Management, Perceptive Advisors and Menlo Ventures, and 15 more. Lead investors include 8VC, Founders Fund, RA Capital and Wellington Management.

How many people work at Synthego?

About 163. Headcount rose from 250 in Jan 2021 to 420 in Dec 2022, then fell to 163 in Oct 2025.

What does Synthego do?

Synthego works in pharmaceutical products, with 14 recorded offerings and customers in biotechnology, life sciences and pharmaceuticals. Its main offerings are CRISPR solutions development, CRISPR gene editing tool manufacturing and engineered nuclease production.

When was Synthego founded, and where is it based?

Synthego was founded in 2012 and is based in Redwood City, United States. It has about 163 employees.

How we value companies Report an issue